3 European Projects Found
Searched on 125080 European Projects
FINISHED
A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease (NILVAD)
Start date: Jan 1, 2012, End date: Dec 31, 2016,
Alzheimer’s disease (AD) is an ever-increasing public health concern among the aging population and is the most common form of dementia affecting more than 15 million individuals worldwide and around 5 million Europeans. The direct and indirect costs of AD and other dementias amount to more than €440,000 million each year (www.alz.org, 2010).Even modest therapeutic advances that delay disease onse ...
Read Project
17
Partners Participants
FINISHED
WINTHERapeutics: development of a systems biology method to predict efficacy of cancer drugs to optimize individualized therapeutic decision and improve clinical outcome for cancer patients (WINTHER)
Start date: Mar 1, 2013, End date: Feb 28, 2015,
Relevance: WINTHER project focuses on the development and validation, in 24 months, of industry supported new tools and computational methods, to predict efficacy of drugs in cancer patientsCurrent medical needs: Selection of cancer targeted therapies based on molecular abnormalities (mutations /amplifications/ translocations) benefit today only to 10-40% of patients. For the remaining majority, ...
Read Project
12
Partners Participants
FINISHED
Atomic QUantum TEchnologies (AQUTE)
End date: Feb 1, 2010,
... many-particle atomic systems are employed to realize special-purpose quantum processors, for instance quantum simulators.Groundbreaking work in qualitatively new directions is also needed to lay the foundations for the future attainment of scalable fault-tolerant architectures. AQUTE will thus also* investigate new experimental systems that have become available in the laboratory and are of direc ...
Read Project
